Background
Slide
We’ll Ensure You Get The Best Pharmaceutical Product

Shinfield Pharmaceuticals is a innovative Pharmaceutical Import and Wholesale Company with offices in Lagos and Anambra Nigeria, with an overarching aim of providing the best quality Pharmaceutical Products in Nigeria and around the world. We believe providing quality pharmaceutical care is key to the health and welbeing of the people we serve around the world

previous arrow
next arrow
Regulatory Compliance
What we do

What We DO

We import and wholesale quality pharmaceutical products to meet healthcare needs across Nigeria.

Importation

Source from reputable global manufacturers

Distribution

Reliable supply across Nigeria

Compliance

Meeting quality and safety standards

What People Say About Us

Elementum in lacus, fermentum dapibus magna lectus ut vel feugiat pellentesque molestie quam venenatis, tempor in.

Diagnostic Lab User Testimonial
ETHAN SHAW

“Metus venenatis cursus ipsum egestas blandit accumsan est feugiat tempus dignissim ante nunc viverra nulla condimentum nunc in sit massa pulvinar tempor mi tortor sapien vel egestas odio bibendum sem ultrices tellus.”

Understanding Myasthenia Gravis: Symptoms, Diagnosis, and Treatment Options

Symptoms of Myasthenia Gravis Diagnosis of Myasthenia Gravis Myasthenia Gravis Treatment Options

admin Avatar
England could lose 16,000 GPs
,

England could lose 16,000 GPs

England could lose 16,000 GPs.

admin Avatar
FDA warns consumers about fraudulent Ebola treatment products

FDA warns consumers about fraudulent Ebola treatment products

FDA warns consumers about fraudulent Ebola treatment products via FDA warns consumers about fraudulent Ebola treatment products. The U.S. Food…

admin Avatar
Coffee may help effects of obesity

Coffee may help effects of obesity

Chemical in coffee may help prevent obesity-related disease Friday, 14 November 2014 Researchers at the University of Georgia have discovered…

admin Avatar
FDA Approves Conversion of Soliris® (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS
,

FDA Approves Conversion of Soliris® (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque auctor aliquam lectus eget venenatis. Nam fermentum est quam, sit amet…

admin Avatar
European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia
,

European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia

European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with HypophosphatasiaEuropean Medicines Agency Accepts…

admin Avatar
Previous slide
Next slide